Raymond S. Douglas
Cedars-Sinai Medical Center · 206 works · 8,264 citations · h-index 47
Top works
- Teprotumumab for Thyroid-Associated Ophthalmopathy
- Teprotumumab for the Treatment of Active Thyroid Eye Disease
- Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease
- SDF-1 Responsiveness Does Not Correlate With CXCR4 Expression Levels of Developing Human Bone Marrow B Cells
- Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy
- Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
- Orbital exenteration: One size does not fit all
- Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves Disease
- Efficacy of “Thick” Acellular Human Dermis (AlloDerm) for Lower Eyelid Reconstruction
- Aberrant Expression of the Insulin-Like Growth Factor-1 Receptor by T Cells from Patients with Graves’ Disease May Carry Functional Consequences for Disease Pathogenesis
- Increased Generation of Fibrocytes in Thyroid-Associated Ophthalmopathy
- B Cells from Patients with Graves’ Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis
- Comparing Outcomes of Enucleation and Evisceration
- Treatment of Lower Eyelid Retraction by Expansion of the Lower Eyelid With Hyaluronic Acid Gel
- Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment
- Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
- Chronic Lymphocytic Leukemia B Cells Are Resistant to the Apoptotic Effects of Transforming Growth Factor-β
- Prevalence of Body Dysmorphic Disorder and Surgeon Diagnostic Accuracy in Facial Plastic and Oculoplastic Surgery Clinics
- Use of Hyaluronic Acid Gel in the Management of Paralytic Lagophthalmos: The Hyaluronic Acid Gel “Gold Weight”
- Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathy